Background <p>Preoperative embolization is often used as an adjunct for intracranial hemangioblastoma (IHB) to reduce intraoperative bleeding. This study aims to evaluate the impact of preoperative embolization on surgical outcomes and patient prognosis by integrating our institutional data with available literature evidence.</p> Methods <p>We included 33 patients who underwent surgery for IHB at our institution from 2019 to 2022. Baseline characteristics, operative duration, intraoperative blood loss, perioperative modified Rankin Scale (mRS) scores, and follow-up outcomes were compared between groups. Furthermore, we systematically searched PubMed, Embase, the Cochrane Library, and Web of Science up to December 2025 for studies comparing preoperative embolization versus direct surgery for IHB.</p> Results <p>The retrospective cohort analysis revealed no significant intergroup differences in age, tumor size, baseline mRS scores, or long-term follow-up outcomes. However, the preoperative embolization group exhibited significantly increased intraoperative blood loss (<i>P</i> = 0.004) and operative duration (<i>P</i> = 0.003). Moreover, the proportion of patients achieving a favorable functional outcome (postoperative mRS score ≤ 2) in the short term (typically defined as within 30&#xa0;days post-surgery) was significantly lower in the embolization group (<i>P</i> = 0.004). The integrated meta-analysis, combining our institutional data with five previously published studies (total <i>N</i> = 269), found that preoperative embolization was not significantly associated with intraoperative blood loss, operative time, functional outcomes, or overall complication rates.</p> Conclusions <p>Based on the integrated analysis of current single-center data and published literature, preoperative embolization for IHB may be associated with increased intraoperative bleeding, prolonged operative time, and worse short-term neurological functional prognosis, without demonstrating the anticipated benefits.</p>